medicine

medicine

A dose of dad’s own medicine : The Tribune India


George N Netto

The pleasant-tasting and mild-acting laxatives available today sometimes make me wonder how we boys stomached the unpalatable potion that was literally forced down our throats in the 1950s. My father had an abiding faith in the efficacy of castor oil as a purgative, having experienced its effectiveness as a boy when it had been forcibly administered to him too. As such, he scorned all popular brands of laxatives, opting for this vile-tasting remedy to thoroughly cleanse our digestive systems, banish constipation and rekindle our waning appetites.

Unsurprisingly, given its foul taste, my brothers and I loathed castor oil. Sometimes the very prospect of having to gulp down half a cup of it, undiluted, made us throw up. Yet it was an ordeal to which we were subjected willy-nilly twice a year, dad’s faith in the laxative being unshakeable.

On a Saturday morning, we would reluctantly queue up before dad, our faces eloquently mirroring our disgust. Often we would jockey to be the last in line, hoping his stock of castor oil would run out. Then, as he poured out a generous measure of the yellow concoction, our domestic help Hassan would pinion our hands behind us, one by one, so that we couldn’t knock the cup out of dad’s hand. And down the hatch the ‘slime’ would be forced as one writhed helplessly, making the wryest of faces that would have been a cartoonist’s delight! Anyone spitting out or throwing up the horrible potion would be promptly given another dose. And, what was worse, no sweets were permitted to neutralise the nauseating taste.

Predictably, about two hours later, our stomachs would begin to churn and rumble, audibly and ominously, signalling that the purgative was at work. And it did! Of course, we did try to somehow wriggle out of the ordeal — feigning a splitting headache, acute stomach pain or even giddiness. But dad shrewdly saw through all our ruses — apparently, he himself had resorted to these as a boy! Once, we even conspired to pool our paltry pocket-money and bribe the shopkeeper down the road into not stocking castor oil. However, the plan was never implemented for fear of dad’s punitive cane.

Once, as D-Day approached, in sheer desperation, we concealed the bottle of castor oil within the folds of dad’s umbrella, confident that he would never look for it there. However, my youngest brother spilled the beans after wresting an assurance from dad that he would be given only half the normal dose of oil.

Quite understandably, few sing the praises of castor oil now — I’m sure youngsters today wouldn’t touch it even with a bargepole. Yet, repulsive though it was, the fact remains that it was indeed an effective purgative that did revive our flagging appetites. No wonder dad swore by its efficacy and administered it dictatorially!

Source Article

Read More
medicine

New program is launched for safe medicine disposal

The Medication Education & Disposal Project has launched a statewide program to offer free services to dispose of expired, unwanted and unused medicines.

Safe Medication Return is operated by MED-Project, which is the Washington State Department of Health’s approved program operator.

Drug manufacturers fund the program at no cost to taxpayers.

MED-Project provides state residents with year-round medicine drop-off locations such as at pharmacies, medical facilities and law enforcement offices. Along with existing operations in several counties, MED-Project has activated about 150 additional drop-off sites.

Residents who prefer mailing back unwanted medicine for disposal can request free prepaid and preauthorized packages. Information is at med-project.org, or people can call (844) 633-7765.

MED-Project also is launching a public awareness campaign about safe disposal of unwanted medicine. A mobile-friendly website provides drop-off location information and instructions, as well as downloadable educational materials.

“We want to encourage Washington state residents to take their medication as prescribed, store it safely and dispose of unwanted or expired medicine securely,” said Dr. Victoria Travis, MED-Project’s national program director, in a news release.

For more information about the MED-Project drug takeback program and available services in Washington state, including accepted types of medication, call (844) 633-7765 or visit the website.

Source Article

Read More
medicine

VYPE Class 6A Helmet Stickers powered by Houston Methodist Orthopedics & Sports Medicine: Week 9 (Nov. 19-21)

Welcome to a new VYPE feature for the 2020 football season – VYPE Helmet Stickers powered by Houston Methodist Orthopedics & Sports Medicine! Every week, VYPE will scour the stat sheets of the previous week and find the top performers.


Class 6A teams went into Week 9 and wow there were some amazing performances! See who earned VYPE Helmet Stickers this week. Here are the selections

PREVIOUS HELMET STICKER SELECTIONS

– Week 1 (Sept. 24-27)
– Week 2 (Oct. 1-3)
– Week 3 (Oct. 8-10)
– Week 4 (Oct. 15-17)
– Week 5 (Oct. 22-24)
– Week 6 (Oct. 29-31)
– Week 7 (Nov. 3-5
– Week 8 (Nov. 12-14)

Carter Brown (@CarterABrown) – Pearland Dawson

Let’s lead this thing off with a kicker! In the epic District 23-6A showdown last week at Freedom Field, it went to overtime between Shadow Creek and Pearland Dawson. After a turnover on its first drive of overtime, Pearland Dawson had a chance to win the game. They got in field goal range and called on All-State kicker Carter Brown. He trotted out and nailed a 23-yard game-winning field goal to clinch the District 23-6A Championship for the Eagles and second-ever undefeated regular season. He also went 4 of 4 in extra point attempts in the game as well.

Daelyn Williams (@sirpaydae) – Dekaney 

Dekaney improved to 3-0 in district play after a 52-7 win over Eisenhower last week. The Wildcats’ offense was paced by Daelyn Williams finished 10 of 14 for 184 yards and three touchdowns. It was a nice win for Dekaney.

Charles Garrett (@3way_tank) – Klein Oak

In a tight 21-14 win over Klein last week, Klein Oak running back Charles Garrett had a nice afternoon. Garrett finished the game rushing for 143 yards and a score on 18 carries. Nice game for the junior back for the Panthers.

Colton Marwill (@CMarwill) – Tomball Memorial

It took a thrilling 49-48 overtime victory over Klein Collins to remain perfect but Tomball Memorial was able to do just that. Colton Marwill has returned at QB after being held out a few weeks due to injury. Marwill looks fully healthy again as he finished 20 of 32 for 328 yards and four touchdowns with two interceptions. Marwill also rushed for another 37 yards.

Cy Park Team! 

We are giving a helmet sticker to the ENTIRE Cy Park football team!! That’s what you get when you make history. Last week a 42-29 win over Langham Creek punched the Tigers’ ticket to the 2020 playoffs. It is the first time in program history that Cy Park is heading to the playoffs. Some individual performances did stand out. The Tigers only had five yards passing for the game but then ran the ball for 475 yards. That’s

Read More
medicine

House panel OKs ‘medicine stockpiling’ bill



calendar: House panel OKs ‘medicine stockpiling’ bill


© Manjunath Kiran/AFP
House panel OKs ‘medicine stockpiling’ bill

MANILA, Philippines — A House panel yesterday approved a bill seeking the stockpiling of medicines for public health emergencies like the current coronavirus pandemic.

The committee on health chaired by Quezon Rep. Helen Tan has approved the substitute to the proposed “Health Procurement and Stockpiling Act,” which seeks to ensure supply of critical drugs, vaccines, devices and materials in times of public health emergencies.

“The COVID-19 pandemic has shown the need to preposition critical and strategic pharmaceuticals and medical devices as well as the supply of raw materials. The country needs to be proactive in its response to public health emergencies,” explained Tan, principal author of the bill.

The bill proposes the creation of the Health Procurement and Stockpiling Bureau under the Department of Health, which will absorb the existing Procurement Service and the Supply Chain Management Service and serve as the principal agency mandated to undertake a transparent, fair, proactive and innovative procurement service for the DOH.

The new bureau will be tasked to stockpile, conserve and facilitate the release of adequate amounts of potentially lifesaving pharmaceuticals, vaccines, devices and materials in times of public health emergencies.

It will also be mandated to identify strategic and critical drugs and medicines, vaccines, devices and materials needed for public health emergencies that have the distinct capability of being stockpiled in strategic and secure areas of the country; supplement drugs and medicines, vaccines, devices and materials to state supplies acting as a stopgap buffer when the immediate supply of adequate amounts of drugs and medicines, vaccines, devices and materials may not be immediately available; and ensure the rotation, replenishment and freshness of stocks and that there exists at all times steady, available and adequate supplies in responding to public health emergencies.

The proposed DOH bureau will also lead in facilitating the creation of a conducive environment to encourage pharmaceutical and device self-sufficiency for medical supplies needed by the country and spearhead the crafting of a multi-sector National Drug and Device Security Program geared towards the country’s self-reliance in producing drugs and medicines, vaccines, devices and materials.

Tan pointed out that based on the Joint External Evaluation Mission report, the Philippines, due to its location, is one of the most natural-disaster prone countries in the world and in the past decade the country has faced challenges in making solid progress in infectious disease control.

“Given this situation, the country’s preparedness in times of public health emergencies is significantly necessary such as during pandemics and natural disasters,” the lawmaker stressed.?

In proposing the measure, Tan lamented how COVID-19 caught the country and the world flatfooted as it affected the global and local production and distribution of pharmaceuticals and medical devices as well as the supply of raw materials.

She recalled how some countries even imposed limits on export of medicines and medical supplies/equipment such as face masks, shields and ventilators to mitigate critical shortages in their countries likewise aggravated the situation.

The lawmaker cited, for

Read More
medicine

Black Friday Vitamin Sales Worth Shopping, From a Doctor

The supplements aisle contains a dizzying amount of products. (Valerian root? Horny goat weed?) Come Black Friday, you’ll be able to shop plenty of these dietary supplements at a major price cut. To help you sort through what’s worth your dollars—and what simply is not—I consulted Matthew Kohler, MD, and Rajivan Maniam, MD, functional medicine doctors and co-founders of Ospina Medical in New York City.

Despite the countless options on the shelf, Dr. Kohler and Dr. Maniam say the average person really only needs to consider five supplements. As always, you should consult your own doctor before adding new supplements to your diet.

The vitamins and supplements to buy on Black Friday

1. Vitamin D

black friday vitamin sales
Photo: Swanson Vitamins

“Vitamin D, the ‘sunshine vitamin,’ has long been pinned as one of the most common vitamin deficiencies that many of us suffer from,” says Dr. Maniam. “While seemingly benign, deficiency in Vitamin D may in fact be propagating pain. To date, there are several observational studies showing an association between vitamin D deficiency and different pain conditions including low back pain, menstrual cramps, and chronic pain.” Dr. Maniam adds that taking vitamin D supplements has the possibility of offering many positives with no known negative side effects, so hey, it’s worth a shot!

Shop Black Friday sale: Vitamin D, $10 (originally $12)

2. Vitamin B12

Photo: HUM

Vitamin B12 is like catnip for the brain—and Dr. Kohler recommends it for anyone who wants some extra cognitive sharpness. “Vitamin B12 is essential for many biological functions and offers numerous known benefits including energy production and assisting in more efficient cellular reproduction,” he says.  B12 is also credited with improving your mood, supporting fetal development, and improving memory—so yeah, it’s worth adding to your medicine cabinet with your doc’s okay.

Shop Black Friday sale: Vitamin B12, up to 50 percent off $10

3. Vitamin C

black friday vitamin sales
Photo: Ancient Nutrition

Vitamin C may be best known for its immune system-boosting abilities, but Dr. Kohler recommends it for another reason. “Vitamin C is a critical nutrient for patients with pain or recent injuries—not only for its anti-inflammatory, antioxidant, and pain-relieving abilities but also for its role in tissue repair and regeneration,” says Dr. Kohler. “Vitamin C helps accelerate the healing process and protects the body from free radical damage. This becomes especially important in patients who have sports injuries such as tendonitis or ligament sprains.” Athletes, this supplement’s for you.

Shop Black Friday sale: Ancient Nutrients Vitamin C + Probiotics, $14 (originally $19)

4. Vitamin K

Photo: Swanson

“Vitamin K works as an enzyme cofactor that has been implicated in inflammation, cardiovascular disease, and osteoarthritis,” says Dr. Maniam. “Inflammation is recognized as a crucial component of many chronic aging diseases and evidence suggests vitamin K has an anti-inflammatory action.”

Shop Black Friday sale: Swanson K-2, Buy one at $10 and get one free

4. Vitamin E

black friday vitamin sales
Photo: HUM

Dr. Maniam says vitamin C is another one that’s essential for anyone who takes their workout

Read More
medicine

Healthsmart M.D. Offers Family Medicine Services In Boca Raton – Press Release

Healthsmart M.D. Offers Family Medicine Services In Boca Raton

Boca Raton, FL – HealthSmart M.D. is a leading medical practice in Boca Raton, FL. The medical practice is focused on delivering leading-edge medical solutions to patients who are faced with medical conditions that threaten their health and wellness. Having been in practice for years, HealthSmart M.D. has been able to address a countless number of conditions by offering a range of treatment solutions to patients.

Patients at the clinic can rest assured that they will have access to a 5-star medical experience from a team of healthcare providers. They are committed to working with patients to restore them to the highest health and wellness standards.

As a private medical practice in Boca Raton, Florida, HealthSmart M.D. guarantees an unparalleled medical treatment experience by offering personalized attention to each patient irrespective of their health challenges. The medical practice boasts of providing a range of services including Family Medicine, Urgent Care, Health – Wellness – Nutrition Programs, Preventative Medicine, IV Therapy, Female and Male Hormone Replacement, Botox Cosmetics, Lip Fillers, and Weight Loss Management.

Describing the approach to treating patients at the clinic, the senior Doctor, Dr. Stephen Silver, said: “By integrating Traditional and Holistic Medicine, we are able to address a wider range of conditions presented by patients. Our programs are based on a trusting “old fashioned” doctor-patient relationship and focus on preventing disease while treating you for acute medical problems that may arise. Stephen Silver, M.D. is a Florida Licensed Medical Doctor who practices Traditional Medicine and may integrate the following Holistic Therapies in his treatment plans: Acupuncture, Acupressure, Nutritional Counseling, Medical Astrology, Detoxification, Energy Medicine.”

Patients who visit the Boca Raton family medicine practice can rest assured that they are at a renowned medical practice that is known for the treatment of patients through a holistic approach with a traditional structure.

HealthSmart M.D. delivers compassionate care services while also addressing common male and female health and wellness challenges. Under the male and female health and wellness programs, patients will be attended to using holistic therapies that have been designed to address common issues associated with age and hormonal declines.

The medical practice also offers a range of injectable solutions to deal with the effects of age on the skin. Some of the injectables offered at the clinic include Botox for treating horizontal forehead lines, crows feet, bunny lines on the nose, drooping brows, and frown lines between the eyebrows. Patients can also enjoy other procedures like Juvederm and Kybella,

HealthSmart M.D. offers IV therapy for the treatment of common signs and symptoms of a weak immune system; medical weight loss solutions for those struggling with an excess fat deposit in the body, as well as other solutions.

The medical practice is located at 98 S Federal Hwy, Boca Raton, FL, 33432, and can be reached on phone for appointment scheduling at 561-368-0777. For more information, send an email to [email protected] or visit their website.

Media Contact
Company Name: HealthSmart M.D.
Contact Person: Dr. Stephen Silver
Email: Send

Read More
medicine

Regenerative Medicine Market 2020 Global Trends Evaluation, Geographical Segmentation, and Investment Opportunities till 2026

The MarketWatch News Department was not involved in the creation of this content.

Nov 25, 2020 (AmericaNewsHour) —
The Regenerative Medicine Market report provides an in-depth analysis of the Healthcare & Pharmaceuticals during the forecast period 2017-2026 which consists of the industry overview including the market size, volume, growth rate and recent trends and developments in the market based on historical and current data. The report covers detailed information about the key players, market segments, growth drivers and restraints in the industry. The report delivers an insight into the Regenerative Medicine Market which allows our clients to make informed decisions regarding the growth of their businesses.

The Regenerative Medicine Market is anticipated to reach over USD 79.23 billion by 2026 according to a new research published by Polaris Market Research. In 2017, the cell therapy dominated the global Regenerative Medicine market, in terms of revenue. North America is expected to be the leading contributor to the global market revenue in 2017.
Regenerative medicine is a branch of medicine that regrows, and repairs the damaged cells in the human body. These medicines include the use of stem cells, tissue engineering, that further helps in developing new organ that function smoothly. These medicines have the caliber of developing an entire organ as these cells are multipotent. The cells are majorly isolated from bone marrow, and umbilical cord blood.

Download free Sample of This Strategic Report:- https://www.kennethresearch.com/sample-request-10070801

The regenerative medicine market is primarily driven by the increasing number of individuals suffering from cancer, rising need to monitor and treating these chronic diseases in the limited time. Furthermore, stringent government policies, proper reimbursement policies, and increasing government healthcare expenditure for developing healthcare infrastructure to also boost the market growth in coming years. Also, rising number of organ transplantation, and increasing number of products in pipeline that are waiting for approval create major opportunity for the regenerative medicines in the coming years. However, some of the ethical and religious concerns for the use of stem cells, and lack of proper regulatory for the approval of various drugs would impede the market growth during the forecast period.

North America generated the highest revenue in the Regenerative Medicine market in 2017, and is expected to be the leading region globally during the forecast period. Increasing number of patients suffering from chronic diseases, improved healthcare infrastructure and health facilities, accessibility of healthcare facilities, are the primary factors driving the market growth in this region. While, Asia Pacific to be the fastest growing region in the coming years. The growth in this region is majorly attributed to the developing healthcare infrastructure of the countries like India, & China, and rising awareness for the use of regenerative medicines as an effective treatment option for chronic diseases.

The key players operating in the Regenerative Medicine market include Organogenesis Inc., Vericel Corporation, Osiris Therapeutics, Inc., Stryker Corporation, and NuVasive, Inc., Medtronic Plc., Acelity, Cook Biotech Inc., Integra LifeSciences, and C.R. Bard. These companies launch new products and collaborate with other market leaders

Read More
medicine

Precision medicine key to preventing disease developing later in life, Singapore News & Top Stories

SINGAPORE – An individual’s genes can determine the amount of risk he has of developing life-threatening conditions such as heart disease and in turn allows for early intervention.

This is central to the precision medicine programme here, said Professor Tan Chorh Chuan, the chief health scientist from the Ministry of Health and executive director at the Healthcare Transformation Office.

Prof Tan told a webinar on Wednesday (Nov 25) that the programme looks at the genome sequences of participants to help determine the cumulative risks of different diseases based on their genes.

This can be particularly useful for some complaints like premature heart disease, added Prof Tan, who was joined on the webinar panel by Prudential chief executive Dennis Tan and Health Promotion Board (HPB) CEO Zee Yoong Kang.

The event, which covered a broad range of health topics from diabetes and vaccines to strategies on how to stay healthy, is part of The Straits Times Reset 2021 webinar series. It was sponsored by Prudential and moderated by ST senior health correspondent Salma Khalik.

Prof Tan told the webinar that a condition known as familial hypercholesterolemia is caused when a person has a gene that results in high cholesterol levels at a much younger age. If that gene is present, the individual will have up to 20 times higher risk of heart disease – and at an earlier age.

“And then if we identify somebody, we can also test the family. So these preventive strategies will be part of precision health,” he added.

The HPB is working to make use of the clinical, behavioural and digital data as well as genetic data – with patient consent – to identify those at higher risk to allow for early intervention.

Prudential’s Mr Tan said Singaporeans need not be worried about being part of the programme or be concerned if they find out their genome sequences. Having “bad” genes will not make it harder for them to secure insurance policies, he assured.

Privacy is really important, Mr Tan said, adding that “we (Prudential) are very, very careful about such things”.

He said individuals ultimately have to take charge of their own health and should find out more. He said: “Preventive healthcare is all about them being in the driver’s seat, and going through the whole process of early detection, health screening and all.

“So I think as insurers, we will definitely support them.”

Ms Khalik noted that if a person learns that he is at a high risk of getting a certain disease, it will give him the time and opportunity to act before the ailment takes hold.

Source Article

Read More
medicine

ZYUS Life Sciences Strengthens Leadership in Evidence-Based Medicine with Appointment of Clinical Advisory Committee

SASKATOON, Saskatchewan–(BUSINESS WIRE)–ZYUS Life Sciences Inc. (“ZYUS”), a Canadian life sciences company leading scientific research and development in phyto-therapeutics, is pleased to announce the formation of a Clinical Advisory Committee to provide strategic advice and guidance on ZYUS’ clinical trial programs. Five committee members have been appointed to the Clinical Advisory Committee, adding additional medical, scientific, and clinical expertise to its experienced leadership team. This announcement is an important step in ZYUS’ integrated clinical development program and supports the company’s ambitions to pioneer the next generation of life sciences through an evidence-based approach.

Chaired by ZYUS’ Chief Medical Officer, Dr. Lionel Marks de Chabris, a leading expert in chronic pain management and addictions medicine, the ZYUS Clinical Advisory Committee includes four initial committee members including Dr. Mary Lynch, Dr. David J. Shulkin, Dr. Cedric Francois and Dr. Alice Zwerling. As ZYUS scales its clinical trial programs, the Clinical Advisory Committee will work closely with the research team to provide input and guidance on clinical development strategies and evaluate the clinical trial progress.

Each of the named Clinical Advisory Committee members bring remarkable medical leadership and expertise to their advisory roles. Dr. Mary Lynch ranks among North America’s leading experts in pain management. She is a Professor in the Departments of Anesthesiology, Pain Management and Perioperative Medicine, Psychiatry and Pharmacology in the Faculty of Medicine at Dalhousie University. In addition to being the founding director of the Canadian Consortium for the Investigation of Cannabinoids, Dr. Lynch co-chairs the Canadian Pain Strategy and is a member of the Royal College of Physicians and Surgeons Working Group on Pain Management. Her expertise in pain management is directly aligned with ZYUS’ research into the potential of phyto-therapeutics to manage chronic and neuropathic pain, and Dr. Lynch’s scientific research and thought-leadership in this space will provide valuable guidance to ZYUS’ clinical approach.

Providing cross-border expertise and widely respected medical leadership, Dr. David J. Shulkin will bring his decades of experience leading some of North America’s largest and most sophisticated medical networks to the ZYUS Clinical Advisory Committee. Dr. Shulkin previously served as the ninth Secretary of the US Department of Veterans Affairs and prior to holding that role, was appointed Under Secretary for Health by President Obama and confirmed unanimously by the U.S. Senate. In his role as Secretary of the U.S. Department of Veterans Affairs, he represented 21 million American veterans and was responsible for the country’s largest integrated health care system with over 1,200 sites of care. In addition to his roles in the public sector, Dr. Shulkin has served as the chief executive of multiple hospitals and health systems, and has been named as one of the “One Hundred Most Influential People in American Healthcare” by Modern Healthcare. Dr. Shulkin’s experience as a physician, hospital CEO and Secretary of the Department of Veterans Affairs provides unique insights into the medical, societal and political implications of ZYUS’ clinical trial programs.

The co-founder and Chief Executive Officer and President of Apellis Pharmaceuticals,

Read More
medicine

NCLA Brief Asks DC Circuit to Stop FDA’s Improper Attempt to Regulate the Practice of Medicine

Washington, D.C., Nov. 24, 2020 (GLOBE NEWSWIRE) — The New Civil Liberties Alliance, a nonpartisan, nonprofit civil rights group, filed an amicus brief in the U.S. Court of Appeals for the District of Columbia Circuit supporting a challenge to a Final Rule issued by the Food and Drug Administration (FDA). The Rule bans “electrical stimulation devices” (ESDs) for aversion therapy, currently in use in only one treatment facility in the United States—the Judge Rotenberg Educational Center in Canton, Massachusetts.

NCLA argues that the statute on which FDA relies does not provide FDA the rulemaking authority it seeks to exercise. Congress adopted the statute to permit FDA to move swiftly to prevent manufacturers from continuing to distribute fraudulent or hazardous medical devices commercially during the time it would take for FDA to prevail in a court proceeding. That rationale is inapplicable when, as here, no manufacturer is seeking to distribute the devices targeted by FDA commercially.

The Center’s professional staff seeks only to continue to use the devices it manufactured many years ago to deter severe self-injurious or aggressive behavior in its own patients. Under those circumstances, the sole enforcement measure available to FDA is a lawsuit seeking an injunction and seizure of the devices—a course of action that would at least have provided Petitioners the hearing rights they were denied in the rulemaking proceeding.

For decades, Massachusetts courts have deemed that the Center’s aversion therapy is both safe and effective for hundreds of patients. Thus, fearing that a federal court would reject its “unreasonable and substantial risk” claim, FDA opted to pursue a rulemaking proceeding. By proceeding in this fashion, for only the third time in its history, FDA was able to prevent the Center from cross-examining FDA’s witnesses and from effectively responding to the assertions FDA made to support its finding.

FDA seeks to prevent the Center from continuing to use its ESDs, but FDA’s rule will allow substantially similar medical devices to continue being used to treat other medical conditions, such as for smoking cessation. NCLA is deeply concerned that FDA has violated the petitioners’ procedural rights and has arrogated to itself powers not delegated to it by Congress. NCLA is asking the court to vacate the rule. 

NCLA released the following statement: 

“Not only is the FDA acting in bad faith, but it’s interfering with the practice of medicine by attempting to dictate how the Center must treat its patients. The law that permits hearing-less bans would violate due process rights—and thus would be simply unconstitutional.”

Rich Samp, Senior Litigation Counsel, NCLA

ABOUT NCLA

NCLA is a nonpartisan, nonprofit civil rights group founded by prominent legal scholar Philip Hamburger to protect constitutional freedoms from violations by the Administrative State. NCLA’s public-interest litigation and other pro bono advocacy strive to tame the unlawful power of state and federal agencies and to foster a new civil liberties movement that will help restore Americans’ fundamental rights.

 

###

 

 


Source Article

Read More